Dear Editor,The coronavirus disease 2019 (COVID‐19) has been associated to a wide variety of skin manifestations, including maculopapular,
vesicular,
urticarial,
livedoid/necrotic
and chilblain‐like acral lesions.
However, there are no previous reports about nail alterations in COVID‐19 patients.A previously healthy 47‐year‐old Spanish male presented to our clinic with asymptomatic nail changes. Forty‐five days before, he had been admitted to the hospital with mild COVID‐19 bilateral pneumonia, confirmed with a positive polymerase chain reaction (PCR) nasopharyngeal swab, and treated with lopinavir/ritonavir 100 mg/400 mg bid for 10 days with a good response and no need for supplemental oxygen therapy. Laboratory findings during his admission were unremarkable, except for mild lymphopenia (830 cells/μL, range 1000‐4500 cells/μL) and a slight elevation of d‐dimer (1330 ng/mL, range 0‐500 ng/mL). During his stay, he noticed the appearance of transverse, nonblanchable white lines on all of his fingernails. These lines did progressively migrate with the growth of the nail and still persisted at the time of the visit (Figure 1). The described findings were compatible with a diagnosis of Mees' lines.
FIGURE 1
Clinical presentation 45 days after admission due to COVID‐19 pneumonia. Transverse, nonblanchable white lines on the fingernails
Clinical presentation 45 days after admission due to COVID‐19 pneumonia. Transverse, nonblanchable white lines on the fingernailsMees' lines, or transverse leukonychia, are a subtype of true leukonychia that were first described by Mees in 1919 secondary to arsenic intoxication.
They have also been associated to other systemic conditions, including heart failure, infectious diseases (leprosy, tuberculosis, malaria, herpes zoster), Hodgkin lymphoma, and the use of chemotherapeutic agents.
,
,
Some authors reserve the name of Mees' lines only for arsenic intoxication, while others use Mees' lines or transverse leukonychia indistinctly. They are thought to be caused by an abnormal keratinization of the nail plate, due to a temporary dysfunction of the nail growth induced by systemic disorders.
Mees' lines disappear after the causative agent has ceased. They can be clinically confused with Muehrcke lines, which represent an abnormality of the nail bed vascularization, usually associated to hypoalbuminemia. Therefore, Muehrcke lines are blanchable lines that do not move with nail growth.This is the first report of nail alterations in a COVID‐19‐positive patient. We hypothesize that the COVID‐19 induced a transitory matrix injury, resulting in Mees' lines, as it has been previously described in other systemic conditions. Given the current incidence rate of COVID‐19, and the wide variety of skin manifestations in these patients, we believe that nail alterations like the current case are probably underreported.
Authors: Lucía Quintana-Castanedo; Marta Feito-Rodríguez; Iván Valero-López; Clara Chiloeches-Fernández; Elena Sendagorta-Cudós; Pedro Herranz-Pinto Journal: JAAD Case Rep Date: 2020-04-29
Authors: C Galván Casas; A Català; G Carretero Hernández; P Rodríguez-Jiménez; D Fernández-Nieto; A Rodríguez-Villa Lario; I Navarro Fernández; R Ruiz-Villaverde; D Falkenhain-López; M Llamas Velasco; J García-Gavín; O Baniandrés; C González-Cruz; V Morillas-Lahuerta; X Cubiró; I Figueras Nart; G Selda-Enriquez; J Romaní; X Fustà-Novell; A Melian-Olivera; M Roncero Riesco; P Burgos-Blasco; J Sola Ortigosa; M Feito Rodriguez; I García-Doval Journal: Br J Dermatol Date: 2020-06-10 Impact factor: 11.113
Authors: Diego Fernandez-Nieto; Juan Jimenez-Cauhe; Ana Suarez-Valle; Oscar M Moreno-Arrones; David Saceda-Corralo; Arantxa Arana-Raja; Daniel Ortega-Quijano Journal: J Am Acad Dermatol Date: 2020-04-24 Impact factor: 11.527
Authors: J D Bouaziz; T A Duong; M Jachiet; C Velter; P Lestang; C Cassius; A Arsouze; E Domergue Than Trong; M Bagot; E Begon; L Sulimovic; M Rybojad Journal: J Eur Acad Dermatol Venereol Date: 2020-07-20 Impact factor: 9.228
Authors: Jennifer Akl; Jessica El-Kehdy; Antoine Salloum; Anthony Benedetto; Paula Karam Journal: J Cosmet Dermatol Date: 2021-07-01 Impact factor: 2.189